PT-141

PT-141, also known as bremelanotide, is a synthetic cyclic peptide studied for its activity within the melanocortin receptor system. It functions as a melanocortin receptor agonist, with research focused primarily on MC3R- and MC4R-mediated signaling.

PT-141 has been investigated in receptor pharmacology, central melanocortin signaling, behavioral neuroscience, and neuroendocrine research. Its mechanism differs from compounds that act primarily through peripheral vascular pathways, making it a distinct subject for controlled laboratory investigation.

Each vial contains 10 mg of PT-141.

This research material is not Vyleesi®, is not an FDA-approved drug product, and is not represented as a generic or therapeutic substitute.

For laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.